CLINICAL_TRIALS
trial_result
· 2006-07-19
Clinical Trial Update: Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder [Phase 3]
Summary
Phase 3 trial evaluating duloxetine versus placebo for prevention of relapse in major depressive disorder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Depressive Disorder | Phase 3 | Status: COMPLETED